Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding

Research output: Contribution to journalArticlepeer-review


Intratumor heterogeneity is thought to be the driving force of tumor evolution and therapy resistance. Yet tools to study these processes are limited. In this issue, Guernet et al. (2016) devised clustered regularly interspaced short palindromic repeats (CRISPR)-barcoding to functionally annotate specific mutations and study clonal evolution in heterogeneous cell populations.

Original languageEnglish
Pages (from-to)352-4
Number of pages3
JournalMolecular cell
Issue number3
Publication statusPublished - 4 Aug 2016
Externally publishedYes


  • Clustered Regularly Interspaced Short Palindromic Repeats
  • Humans
  • Mutation
  • Oncogenes


Dive into the research topics of 'Who Is in the Driver's Seat: Tracing Cancer Genes Using CRISPR-Barcoding'. Together they form a unique fingerprint.

Cite this